Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG study

Annals of Oncology : Official Journal of the European Society for Medical Oncology
M BawejaNCCTG

Abstract

A one-stage phase II trial was conducted to assess the tumor response rate and toxicity profile of single agent oral vinorelbine as first or second-line chemotherapy for women at least 65 years of age with metastatic breast cancer. Twenty-five patients with metastatic breast cancer aged > or = 65 years of age were enrolled to receive oral vinorelbine on a weekly basis. The oral vinorelbine was given at 60 mg/m2 weekly for the first four doses and was increased to 70 mg/m2 for the subsequent administrations if there was no grade 4 neutropenia or no more than one episode of grade 3 neutropenia. Therapy was continued until progression or intolerable toxicity. Twenty-five patients were included and evaluable for analysis. One patient (4%) achieved a partial response (PR) that lasted for more than 13 months. Two additional patients remained stable for at least 6 months for a clinical benefit rate (PR + stable disease) of 12%. The 1-year survival rate was estimated to be 48% (95% CI 30% to 74.5%). Median time to progression was estimated to be 4.7 months (95% CI 2.0-5.5 months) and the 9-month disease progression-free rate was estimated to be 8% (95% CI 30.9% to 74.5%). The treatment was fairly well tolerated with grade 3 neutropenia...Continue Reading

References

Nov 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B L WeberJ Hohneker
Nov 1, 1994·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J García-CondeA Cervantes
Oct 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C ToussaintG G Chabot
Nov 1, 1994·British Journal of Cancer·C J TwelvesR D Rubens
May 1, 1994·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M DegardinA Demaille
Sep 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E K RowinskyD S Ettinger
Feb 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A RomeroL Romero Acuña
Jan 1, 1996·Breast Cancer Research and Treatment·M TerenzianiG Bonadonna
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G LiuE Warner
Apr 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R B LivingstonC A Long
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G K EllisR B Livingston
Jun 17, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C VogelC McGuirt
Mar 31, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D I UdomR C Coombes
Jun 1, 2000·Breast Cancer Research and Treatment·C NisticòE Terzoli
Oct 3, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A BerrutiL Dogliotti
Jan 5, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J JassemA Depierr
Feb 2, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M MartyC Puozzo
Feb 15, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BonneterreM Piccart
May 2, 2002·Journal of the National Cancer Institute·Ann H PartridgeEric P Winer
Jun 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrizia ViciMassimo Lopez
Oct 3, 2002·Cancer Chemotherapy and Pharmacology·Roland BugatIsabelle Senac
Nov 16, 2002·British Journal of Cancer·V J O'Neill, C J Twelves
Mar 15, 2003·Clinical Breast Cancer·Carlos Jara-SánchezUNKNOWN Spanish Group for Research in Breast Cancer
May 20, 2004·British Journal of Cancer·J E HusbandUNKNOWN International Cancer Imaging Society
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bent EjlertsenUNKNOWN Scandinavian Breast Group Trial (SBG9403
Jun 22, 2005·Cancer Treatment Reviews·Ignazio CarrecaMartine Extermann

❮ Previous
Next ❯

Citations

Sep 17, 2009·Breast Cancer : the Journal of the Japanese Breast Cancer Society·David RossiStefano Luzi Fedeli
Oct 3, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M LuqueY Fernández
May 6, 2015·Expert Opinion on Drug Metabolism & Toxicology·Jasmeet C Singh, Stuart M Lichtman
May 20, 2011·Cancer Treatment Reviews·Marc DebledPierre Soubeyran
Apr 16, 2010·The Breast : Official Journal of the European Society of Mastology·A A KotsoriI E Smith
Mar 8, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lev Bromberg
Dec 1, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jos J KitzenJaap Verweij
May 15, 2013·Journal of Veterinary Internal Medicine·J A PierroC F Saba
May 11, 2017·Breast Cancer Research and Treatment·B CabarrouThomas Filleron
Oct 8, 2018·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·I BlancasA Llombart
Jul 7, 2018·Drug Delivery and Translational Research·Sumayah Al-MahmoodTamara Minko
Mar 28, 2007·Drugs·Matti S AaproVéronique Trillet-Lenoir

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.